| abstract |
Activated haptens useful for generating immunogens to HIV protease inhibitors,nimmunogens useful for producing antibodies to HIV protease inhibitors, and antibodiesnand labeled conjugates useful in immunoassays for HIV protease inhibitors. The novelnhaptens feature an activated functionality at the central, non-terminal hydroxyl groupncommon to all HIV protease inhibitors, e.g., saquinavir, nelfinavir, indinavir, amprenavir,nritonavir, lopinavir, and atazanavir. |